Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.

Conditions

• Atrial Fibrillation (AF)

Interventions

• DRUG: BAY2433334
• DRUG: Apixaban
• OTHER: BAY2433334 matching placebo
• OTHER: Apixaban matching placebo

Sponsor

Bayer